文献速递流行病学与生物统计医学教育与科研方法

癌症核心结局集开发标准亟需改进

Improvement was needed in the standards of development for cancer core outcome sets.
PubMed 文献 · J Clin Epidemiol · 2019-04-19

该研究以系统综述识别的307项已发表核心结局集(COS)研究为基础,纳入49项癌症COS,由两名评价者独立依据COS-STAD的12条标准(代表11项最低设计推荐)进行评估。结果显示无一项癌症COS满足全部12条标准(范围4–11条,中位数6条);全部研究均满足4条范围标准,8项(16%)满足全部3条利益相关者标准,2项(4%)满足全部4条共识过程标准。作者结论认为,除范围界定外,癌症COS开发标准亟需改进,报告不佳常导致难以评估是否达到最低标准。

要点

  • 49项癌症核心结局集均未满足COS-STAD全部12条标准,达标数范围4–11条,中位数6条。
  • 全部研究满足4条范围标准,8项(16%)满足全部3条利益相关者标准。
  • 仅2项(4%)满足全部4条共识过程标准,共识过程标准最难评估。

核心结论

  • 除范围界定外,癌症核心结局集的开发标准亟需大幅改进。
  • 报告不佳常使评估是否达到最低标准变得困难,共识过程标准(尤其需评估是否事先设定者)最难评估。
  • 这是COS-STAD标准首次应用于开发核心结局集的研究,提供了癌症核心结局集开发标准的基线。

研究设计与样本

  • 基于系统综述识别的307项已发表核心结局集研究,纳入癌症核心结局集。
  • 由两名评价者独立依据COS-STAD的12条标准(代表11项最低设计推荐)对每项核心结局集进行评估。

主要发现

  • 共纳入49项癌症核心结局集,无一项满足全部12条标准(范围4–11条,中位数6条)。
  • 全部研究满足4条范围标准。
  • 8项(16%)满足全部3条利益相关者标准。
  • 2项(4%)满足全部4条共识过程标准。

关键数值与推荐

  • COS-STAD包含11项标准(12条准则),被视为所有核心结局集开发项目的最低设计推荐。
  • 癌症核心结局集满足标准数范围4–11条,中位数6条;全部满足范围标准,8项(16%)满足全部利益相关者标准,2项(4%)满足全部共识过程标准。

局限性

  • 报告不佳常使评估核心结局集是否达到最低标准变得困难。
  • 共识过程标准最难评估,尤其是需要评估是否事先设定的标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Core Outcome Set-STAndards for Development (COS-STAD) contains 11 standards (12 criteria) that are deemed to be the minimum design recommendations for all core outcome set (COS) development projects. Cancer is currently the disease area with the highest number of published COSs and is a major cause of worldwide morbidity and mortality. The aim of this study was to provide a baseline of cancer COS standards. STUDY DESIGN AND SETTING: Systematic reviews of COSs have identified 307 published COS studies. Cancer COSs were eligible for inclusion. Two reviewers independently assessed each of the COSs against the 12 criteria. RESULTS: Forty-nine cancer COSs were included; none met all 12 criteria representing the 11 minimum standards assessed in this study (range = 4-11 criteria, median = 6 criteria). All studies met the four scope standards, eight (16%) met all three standards for stakeholders involved, and two (4%) met all four standards for consensus process standards. CONCLUSION: With the exception of "scope" specification, there is much need for improvement. Poor reporting often made it challenging to assess whether minimum standards were met. The consensus process criteria were most difficult to assess, particularly those that required an assessment of being a priori. This is the first application of COS-STAD criteria to studies that have developed COSs and provides a baseline of cancer COS standards of development.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Gargon E, Williamson PR, Blazeby JM, et al. Improvement was needed in the standards of development for cancer core outcome sets. J Clin Epidemiol. 2019. PMID: 31009657. doi:10.1016/j.jclinepi.2019.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。